BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Debt / NOTE 1.250% 5/1
Principal, excl. options Q3 2024
411M
Holdings value Q3 2024
$392M
Value change Q3 2024
+$35.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
60
Number of buys Q3 2024
23
Number of sells Q3 2024
-23
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $411M $392M +$35.7M $0.95 60
2024 Q2 $374M $359M -$26.4M $0.96 57
2024 Q1 $400M $397M +$12.8M $0.99 56
2023 Q4 $392M $404M +$15.2M $1.03 56
2023 Q3 $377M $375M +$15.1M $0.99 48
2023 Q2 $362M $366M +$30.2M $1.01 47
2023 Q1 $333M $347M +$74.4M $1.04 44
2022 Q4 $245M $264M +$27.1M $1.08 42
2022 Q3 $209M $209M -$111M $1.00 36
2022 Q2 $320M $319M -$3.64M $1.00 34
2022 Q1 $323M $326M +$105M $1.00 28
2021 Q4 $217M $227M -$32.5M $1.04 31
2021 Q3 $246M $248M +$2.61M $1.00 25
2021 Q2 $244M $245M +$245M $1.00 27